David A. Siegel Blue Water Vaccines Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.51 - $1.2 $561 - $1,320	-1,100 Reduced 9.91%	10,000 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.79 - $1.29 $3,318 - $5,418	-4,200 Reduced 27.45%	11,100 $12,000
Q1 2023 May 15, 2023	SELL	$1.01 - $1.56 $4,141 - $6,396	-4,100 Reduced 21.13%	15,300 $16,000
Q4 2022 Feb 14, 2023	SELL	$0.92 - $1.46 $2,760 - $4,380	-3,000 Reduced 13.39%	19,400 $21,000
Q3 2022 Nov 14, 2022	SELL	$1.78 - $6.66 $3,382 - $12,654	-1,900 Reduced 7.82%	22,400 $38,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $63.0 $51,759 - $1.53 Million	24,300 New	24,300 $52,000

2.95M

Ticker BWV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,744,900
Market Cap $2.34M
Description
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.